Amphenol
APH
$123.05
+3.23%
Amphenol Corporation is a global leader in the design and manufacture of connectors, sensors, and interconnect systems, operating within the technology hardware, equipment, and parts industry. The company holds the position of the world's second-largest connector supplier, serving a highly diversified set of end markets including automotive, industrial, IT/data communications, and aerospace, which provides it with a resilient and broad-based competitive identity. The current investor narrative is focused on the company's ability to navigate a mixed demand environment, with recent news highlighting opportunistic insider selling amidst a significant stock price rally, raising questions about near-term valuation and growth sustainability after a period of strong performance.…
APH
Amphenol
$123.05
Related headlines
Investment Opinion: Should I buy APH Today?
Rating & Thesis: Hold. Amphenol is a fundamentally strong company caught in a valuation and momentum reset; investors should wait for a better entry point or clearer signs of growth stabilization before committing new capital. This aligns with the implied bullish consensus from analysts but tempers it with the stock's recent technical breakdown and premium valuation.
Supporting Evidence: The Hold rating is supported by four key data points: 1) The forward P/E of 22.2x is reasonable for a company with its growth profile, but the trailing P/E of 38.6x shows how far it has run. 2) Revenue growth is exceptional at 49% YoY, but the sustainability is the core question. 3) Profitability is robust with an 18.5% net margin and $4.38B in TTM FCF. 4) The stock trades 25.2% below its 52-week high, indicating a significant correction has already occurred, limiting near-term downside.
Risks & Conditions: The two biggest risks are a growth deceleration triggering multiple compression and continued high volatility (beta 1.3) pressuring the stock in a risk-off market. This Hold would upgrade to a Buy if the forward P/E compressed further towards 20x, or if quarterly revenue growth stabilizes above 30% YoY. It would downgrade to a Sell if revenue growth decelerates sharply below 20% or if the stock breaks below its recent low of $119.15 with conviction. The stock is currently fairly valued to slightly overvalued relative to its own history, but not egregiously so given its quality and growth.
Sign up to view all
APH 12-Month Price Forecast
The outlook for APH is one of high-quality growth at a fair price, following a significant correction. The base case (55% probability) of range-bound trading is most likely, as the market digests the transition from hyper-growth to sustainable premium growth. The bullish analyst sentiment is a positive counterweight to recent technical weakness. The stance would upgrade to Bullish on a confirmed breakout above $160 with volume, signaling the correction is over. It would downgrade to Bearish on a breakdown below $119, which would indicate the growth scare is more severe than anticipated.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amphenol's 12-month outlook, with a consensus price target around $159.97 and implied upside of +30.0% versus the current price.
Average Target
$159.97
4 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
4
covering this stock
Price Range
$98 - $160
Analyst target range
Amphenol is covered by a limited set of four analysts, indicating it may have less broad institutional coverage than some mega-cap peers, which can contribute to higher volatility. The consensus sentiment, inferred from recent institutional actions, is bullish, with multiple firms including Jefferies, Barclays, Citigroup, JP Morgan, and UBS maintaining or upgrading to Buy or Overweight ratings in early 2026. While a specific average target price is not provided in the dataset, the recent upgrades and sustained bullish calls suggest analysts see fundamental strength and potential upside. The target range, based on estimated revenue and EPS, shows a high degree of uncertainty; for example, revenue estimates for the coming period range from $44.28 billion to $48.32 billion, a spread of over $4 billion, and EPS estimates range from $7.10 to $7.96. This wide dispersion in forecasts signals differing views on the company's near-term growth trajectory and margin outlook, reflecting the challenges in modeling demand across its diverse end markets. The pattern of recent analyst actions, including Barclays' upgrade from Equal Weight to Overweight in January 2026, points to a building positive momentum in analyst sentiment following the company's financial releases.
Bulls vs Bears: APH Investment Factors
The bull case for Amphenol is anchored in its exceptional 49% revenue growth, robust profitability, strong cash generation, and supportive analyst sentiment. The bear case focuses on its premium valuation relative to history, recent sharp price correction, high volatility, and the uncertainty signaled by wide analyst forecast ranges. Currently, the bearish evidence from the technical breakdown and valuation concerns holds stronger weight in the near term, as the stock is actively repricing from recent highs. The single most important tension in the investment debate is whether the company's stellar 49% YoY revenue growth can be sustained or even moderately decelerated without triggering a severe multiple compression from its elevated trailing P/E of 38.6x.
Bullish
- Exceptional Revenue Growth: Q4 2025 revenue grew 49.12% year-over-year to $6.44 billion, demonstrating robust demand across its diversified end markets. This sequential growth from $4.81B in Q1 2025 to the Q4 peak indicates strong operational momentum.
- Strong Profitability & Cash Flow: The company maintains high profitability with a Q4 net margin of 18.49% and an operating margin of 25.86%. It generates substantial free cash flow ($4.38B TTM), supporting a strong balance sheet with a current ratio of 2.98 and a 31.84% ROE.
- Analyst Sentiment Bullish: Multiple major firms (Jefferies, Barclays, Citigroup, JP Morgan, UBS) have maintained or upgraded to Buy/Overweight ratings in early 2026. Barclays' upgrade from Equal Weight to Overweight in January 2026 signals building positive momentum in analyst conviction.
- Attractive Forward Valuation: The stock's forward P/E of 22.21x represents a significant discount to its trailing P/E of 38.55x, implying the market expects strong earnings growth. The PEG ratio of 0.52 suggests the stock may be undervalued relative to its growth rate.
Bearish
- Premium Historical Valuation: The trailing P/E of 38.55x is elevated relative to its own historical range, suggesting the stock is pricing in optimistic expectations. The EV/EBITDA of 24.52x and P/S of 7.13x further confirm a premium valuation that requires flawless execution.
- Sharp Recent Price Correction: The stock is down 14.95% over the past month and 14.80% over three months, underperforming the S&P 500 by over 20% in the last month. This technical breakdown, with a 28.33% max drawdown, signals a potential reassessment of growth expectations.
- High Volatility & Insider Selling: A beta of 1.297 makes the stock ~30% more volatile than the market, amplifying downside risk. Recent news highlighted opportunistic insider selling during the rally, which can be perceived as a lack of confidence in near-term valuation sustainability.
- Wide Analyst Forecast Dispersion: Revenue estimates for the coming period range from $44.28B to $48.32B (a $4B+ spread), and EPS estimates range from $7.10 to $7.96. This high uncertainty reflects challenges in modeling demand across diverse markets and creates potential for earnings misses.
APH Technical Analysis
The prevailing price trend for Amphenol has been a volatile consolidation within a wide range following a powerful uptrend, as evidenced by the stock's 45.40% gain over the past year. The current price of $125 sits approximately 49.5% above its 52-week low of $83.44 and 25.2% below its 52-week high of $167.04, positioning it in the lower-middle portion of its annual range, suggesting a potential value opportunity after a significant correction from recent highs. Recent momentum has been sharply negative and diverging from the longer-term uptrend, with the stock down 14.95% over the past month and 14.80% over the past three months, indicating a pronounced short-term pullback that has erased the year-to-date gains, which now stand at -10.53%. This divergence signals a potential mean reversion or a reassessment of growth expectations, exacerbated by the stock's high beta of 1.297, which makes it approximately 30% more volatile than the broader market, amplifying both gains and losses during market swings. Key technical levels are clearly defined by the 52-week high of $167.04 as major resistance and the 52-week low of $83.44 as critical support; a sustained breakout above resistance would signal a resumption of the primary bull trend, while a breakdown below the recent low of $119.15 from March 30, 2026, could open the door for a test of the 52-week low. The stock's elevated volatility, as confirmed by its beta, necessitates careful risk management, especially given the recent 28.33% maximum drawdown experienced during this corrective phase.
Beta
1.30
1.30x market volatility
Max Drawdown
-28.3%
Largest decline past year
52-Week Range
$83-$167
Price range past year
Annual Return
+42.6%
Cumulative gain past year
| Period | APH Return | S&P 500 |
|---|---|---|
| 1m | -19.5% | +4.6% |
| 3m | -18.6% | +8.3% |
| 6m | -6.5% | +12.5% |
| 1y | +42.6% | +25.0% |
| ytd | -11.9% | +8.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
APH Fundamental Analysis
Amphenol's revenue trajectory demonstrates robust growth, with Q4 2025 revenue reaching $6.44 billion, representing a substantial 49.12% year-over-year increase. This growth has been sequential, with quarterly revenues climbing from $4.81 billion in Q1 2025 to the Q4 peak, indicating strong demand across its diversified end markets, particularly in the Communications Solutions segment, which contributed $3.53 billion in the latest period. The company is highly profitable, with Q4 2025 net income of $1.20 billion and a gross margin of 38.22%, reflecting its premium product positioning and operational efficiency. Profitability metrics are strong and stable, with a net margin of 18.49% and an operating margin of 25.86%, although the quarterly net margin has fluctuated between 15.34% and 20.11% through 2025, showing some variability amidst growth investments. The balance sheet and cash flow position is solid, with a strong current ratio of 2.98 and a manageable debt-to-equity ratio of 1.16. The company generates substantial cash, with trailing twelve-month free cash flow of $4.38 billion, providing ample internal funding for growth initiatives, share repurchases, and dividends, as evidenced by a healthy return on equity of 31.84%.
Quarterly Revenue
$6.4B
2025-12
Revenue YoY Growth
+0.49%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$4.4B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is APH Overvalued?
Given Amphenol's substantial net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The stock currently trades at a trailing PE of 38.55x, which is significantly higher than the forward PE of 22.21x, indicating the market expects strong earnings growth to justify the current price. Compared to sector averages implied by its own historical data, the current trailing PE of 38.55x is elevated relative to its historical range observed over the past several years, which has typically fluctuated between the high-teens and low-30s. This suggests the stock is trading at a premium to its own historical valuation norms, potentially pricing in optimistic expectations for sustained high growth and margin performance. The forward PE discount to the trailing multiple implies anticipated earnings per share growth, with analysts projecting an average EPS of $7.54 for the coming period, which would represent a significant increase from recent quarterly EPS figures. The stock's Price-to-Sales ratio of 7.13x and EV/EBITDA of 24.52x further confirm a premium valuation, requiring consistent execution on growth and profitability targets to be sustained.
PE
38.6x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 20x~39x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
24.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Amphenol's primary financial risk is valuation compression, given its premium trailing P/E of 38.55x and EV/EBITDA of 24.52x, which are elevated relative to its historical norms. While the balance sheet is solid (Debt/Equity of 1.16), the company's earnings are sensitive to margin fluctuations, as seen in quarterly net margins ranging from 15.3% to 20.1% in 2025. A deceleration from the current 49% revenue growth rate could significantly pressure the stock's premium multiple, as the forward P/E of 22.2x already embeds high growth expectations.
Market & Competitive Risks: The stock's high beta of 1.297 exposes it to amplified losses during market downturns, as evidenced by its 28.3% maximum drawdown and severe underperformance versus the S&P 500 over the last three months (-23.2% relative strength). Competitive risks are inherent in the connector industry, though its #2 global market share provides a moat. The wide dispersion in analyst revenue estimates ($44.3B to $48.3B) indicates significant uncertainty about end-market demand, particularly in key segments like Communications Solutions, which contributed $3.53B in Q4.
Worst-Case Scenario: The worst-case scenario involves a combination of a broader market sell-off (exacerbated by the stock's high beta) and a company-specific earnings miss due to demand softening in a key end market. This could trigger a wave of analyst downgrades and a rapid de-rating towards its historical valuation lows. The realistic downside could see the stock retesting its 52-week low of $83.44, representing a potential loss of approximately -33% from the current price of $125. A more immediate bear-case target would be the recent low of $119.15, representing a -5% downside.
FAQ
The key risks are: 1) Valuation & Multiple Compression: The stock's premium trailing P/E (38.6x) is vulnerable if its exceptional 49% revenue growth decelerates. 2) Market Volatility: With a beta of 1.3, APH will likely fall more than the market in a downturn, as seen in its recent 28% drawdown. 3) Cyclical Demand: Its diversified end markets (auto, industrial, IT) are cyclical; a broad economic slowdown would hurt revenue. 4) Execution Risk: Wide analyst forecast ranges (EPS $7.10-$7.96) indicate uncertainty, raising the risk of earnings misses that could trigger sell-offs.
The 12-month forecast presents three scenarios. The Base Case (55% probability) sees the stock trading between $140 and $160, as growth moderates but remains strong, and the forward P/E holds around 22x-25x. The Bull Case (30% probability) targets $167 to $180 if growth re-accelerates and the stock retests its highs. The Bear Case (15% probability) sees a drop to $100-$120 if a recession hits its end markets. The most likely outcome is the Base Case, predicated on the assumption that revenue growth decelerates to a sustainable mid-teens pace without a severe multiple contraction.
APH is fairly valued to slightly overvalued relative to its own historical norms but not excessively so given its growth profile. The trailing P/E of 38.55x is at a premium to its historical range, but the forward P/E of 22.21x implies significant earnings growth is already priced in. Key valuation metrics like EV/EBITDA (24.5x) and P/S (7.1x) also suggest a premium. The market is paying for sustained high growth and margin excellence. If the company delivers on its forward EPS estimate of $7.54, the current valuation is justifiable; if it misses, the stock is overvalued.
APH is a good stock for investors seeking a high-quality, diversified industrial growth company, but timing is crucial. At the current price of $125, it is 25% off its highs and trades at a forward P/E of 22.2x, which is more reasonable than its trailing multiple of 38.6x. The 33% potential downside to its 52-week low is a material risk, exacerbated by its high beta of 1.3. It is a good buy for patient, long-term investors who can dollar-cost average on weakness, but not for short-term traders or those with low risk tolerance.
APH is more suitable for a long-term investment horizon (3-5 years minimum). Its high beta (1.3) and recent volatility make it a challenging short-term trade. As a global market leader with a proven growth and profitability track record, its long-term thesis of gaining share across expanding end markets like EVs and data centers is intact. The stock does not pay a meaningful dividend (yield ~0.5%), so the return is primarily driven by capital appreciation. Investors should be prepared to weather significant interim volatility, making it ill-suited for short-term portfolios.
